To study the effect of Milrinone administered via respiratory tract on the function of right and left heart assessed using echocardiography.
Not Applicable
- Conditions
- Health Condition 1: I259- Chronic ischemic heart disease, unspecifiedHealth Condition 2: I083- Combined rheumatic disorders of mitral, aortic and tricuspid valves
- Registration Number
- CTRI/2024/03/064657
- Lead Sponsor
- All India Institutes of Medical sciences Jodhpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
SCHEDULED FOR ELECTIVE ON PUMP CARDIAC SURGERY
Exclusion Criteria
PATIENT REFUSAL, EMERGENCY CARDIAC SURGERY, PATIENTS ON MECHANICAL CIRCULATORY SUPPORT, OFF PUMP SURGERY, ALLERGIC TO MILRINONE
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To observe the effects of inhaled milrinone on right sided cardiac chamber parameters RV size, RA pressure, RV systolic function (TAPSE, S PRIME, FAC), pulmonary artery diameter (MPA, LPA, RPA), PASP in patients undergoing on pump cardiac surgeryTimepoint: From starting of the surgery to end of the surgery
- Secondary Outcome Measures
Name Time Method TO OBSERVE THE EFFECT OF INHALED MILRINONE ON LEFT SIDED CARDIAC CHAMBER PARAMETERS LV SIZE, LV VOLUME, LV SYSTOLIC FUNCTION IN PATIENTS UNDERGOING ON PUMP CARDIAC SURGERIESTimepoint: FROM STARTING OF THE SURGERY TO END OF THE SURGERY